SPDR S&P Biotech ETF $XBI Shares Sold by Lyell Wealth Management LP

Lyell Wealth Management LP decreased its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 77.4% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,288 shares of the exchange traded fund’s stock after selling 11,240 shares during the quarter. Lyell Wealth Management LP’s holdings in SPDR S&P Biotech ETF were worth $273,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of XBI. Prime Capital Investment Advisors LLC raised its holdings in SPDR S&P Biotech ETF by 37.9% in the 2nd quarter. Prime Capital Investment Advisors LLC now owns 9,939 shares of the exchange traded fund’s stock valued at $824,000 after acquiring an additional 2,729 shares during the last quarter. Cerity Partners LLC raised its holdings in SPDR S&P Biotech ETF by 5.8% in the 1st quarter. Cerity Partners LLC now owns 18,605 shares of the exchange traded fund’s stock valued at $1,509,000 after acquiring an additional 1,016 shares during the last quarter. Farther Finance Advisors LLC raised its holdings in SPDR S&P Biotech ETF by 574.5% in the 2nd quarter. Farther Finance Advisors LLC now owns 7,082 shares of the exchange traded fund’s stock valued at $587,000 after acquiring an additional 6,032 shares during the last quarter. N.E.W. Advisory Services LLC acquired a new stake in SPDR S&P Biotech ETF in the 1st quarter valued at about $95,000. Finally, Investment Partners Asset Management Inc. raised its holdings in SPDR S&P Biotech ETF by 4.0% in the 2nd quarter. Investment Partners Asset Management Inc. now owns 3,257 shares of the exchange traded fund’s stock valued at $270,000 after acquiring an additional 125 shares during the last quarter.

SPDR S&P Biotech ETF Trading Up 2.2%

XBI stock opened at $110.17 on Tuesday. The company has a market cap of $6.84 billion, a price-to-earnings ratio of 11.47 and a beta of 0.97. SPDR S&P Biotech ETF has a 12 month low of $66.66 and a 12 month high of $110.96. The firm has a 50-day moving average of $96.56 and a two-hundred day moving average of $86.95.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.